{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:44:01Z","timestamp":1792608241395,"version":"4.5.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.disamonth.2022.101465","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T22:23:38Z","timestamp":1661207018000},"page":"101465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature"],"prefix":"10.1016","volume":"68","author":[{"given":"Kirsten","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Deleveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beje","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Madariaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0001","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000441-191911000-00012","article-title":"The significance of certain pulmonary lesions in relation to the etiology of influenza","volume":"158","author":"Goodpasture","year":"1919","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0002","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archinte.1996.00440040118013","article-title":"The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition","volume":"156","author":"Niles","year":"1996","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2796.1995.tb00912.x","article-title":"Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome","volume":"238","author":"Saxena","year":"1995","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/ajkd.2002.29876","article-title":"Pulmonary renal syndrome: a 4-year, single-center experience","volume":"39","author":"Gallagher","year":"2002","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/cc5778","article-title":"Bench-to-bedside review: pulmonary-renal syndromes\u2013an update for the intensivist","volume":"11","author":"Papiris","year":"2007","journal-title":"Crit Care Lond Engl"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101465_bib0006","first-page":"e12089","article-title":"Anti-glomerular basement membrane disease as a potential complication of COVID-19: a case report and review of literature","volume":"12","author":"Nahhal","year":"2020","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0007","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/rheumatology\/keg322","article-title":"Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit","volume":"42","author":"Cruz","year":"2003","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0009","doi-asserted-by":"crossref","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","article-title":"An update on the epidemiology of ANCA-associated vasculitis","volume":"59","author":"Mohammad","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0010","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"McAdoo","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0011","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/ki.1996.495","article-title":"Goodpasture's syndrome","volume":"50","author":"Bolton","year":"1996","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0012","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis","volume":"350","author":"Contreras","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0013","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2003.014175","article-title":"Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients","volume":"63","author":"Cervera","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0014","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccm.2004.04.007","article-title":"Diffuse alveolar hemorrhage","volume":"25","author":"Collard","year":"2004","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5582\/irdr.2016.01014","article-title":"Granulomatosis with polyangiitis (Wegener's disease): an updated review of ocular disease manifestations","volume":"5","author":"Kubaisi","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.disamonth.2022.101465_bib0016","series-title":"StatPearls","article-title":"Granulomatosis with polyangiitis","author":"Garlapati","year":"2022"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0017","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2010.04.003","article-title":"Microscopic polyangiitis","volume":"36","author":"Chung","year":"2010","journal-title":"Rheum Dis Clin N Am"},{"issue":"Supplement_3","key":"10.1016\/j.disamonth.2022.101465_bib0018","doi-asserted-by":"crossref","first-page":"iii84","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli","year":"2020","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.disamonth.2022.101465_bib0019","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5414\/CN109206","article-title":"Familial antiglomerular basement membrane disease in zero human leukocyte antigen mismatch siblings","volume":"88","author":"Angioi","year":"2017","journal-title":"Clin Nephrol"},{"issue":"8364","key":"10.1016\/j.disamonth.2022.101465_bib0020","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0140-6736(83)90923-6","article-title":"Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane","volume":"2","author":"Donaghy","year":"1983","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0021","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ckj\/sfw038","article-title":"Multiple recurrences of anti-glomerular basement membrane disease with variable antibody detection: can the laboratory be trusted?","volume":"9","author":"Liu","year":"2016","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0022","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ckj\/sfw048","article-title":"Frequently relapsing anti-glomerular basement membrane antibody disease with changing clinical phenotype and antibody characteristics over time","volume":"9","author":"Gu","year":"2016","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0023","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.autrev.2014.11.006","article-title":"Goodpasture's syndrome: a clinical update","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.1973.14","article-title":"Anti-glomerular basement membrane antibody-induced glomerulonephritis","volume":"3","author":"Wilson","year":"1973","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.disamonth.2022.101465_bib0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti\u2013glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.04290417","article-title":"Predicting outcome in patients with anti-GBM glomerulonephritis","volume":"13","author":"van Daalen","year":"2018","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.disamonth.2022.101465_bib0027","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2019.01665","article-title":"Prognostic factors in anti-glomerular basement membrane disease: a multicenter study of 119 patients","volume":"10","author":"Marques","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.autrev.2011.08.002","article-title":"Immune regulatory mechanisms in ANCA-associated vasculitides","volume":"11","author":"Lepse","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/art.37959","article-title":"ANCA-associated vasculitis patients have defective treg function exacerbated by presence of a suppression-resistant effector population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0031","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.03501006","article-title":"Association of silica exposure with anti\u2013neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study","volume":"2","author":"Hogan","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0032","doi-asserted-by":"crossref","unstructured":"Guilpain P., Servettaz A., Goulvestre C., et\u00a0al. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. Arthritis Rheum. 2007;56(7):2455-2463. doi:10.1002\/art.22741.","DOI":"10.1002\/art.22741"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101465_bib0033","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","article-title":"Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides","volume":"2","author":"Kallenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0b013e328011cb80","article-title":"Controversies in small vessel vasculitis\u2013comparing the rheumatology and nephrology views","volume":"19","author":"Falk","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0036","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0038","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status","volume":"10","author":"Lyons","year":"2019","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.disamonth.2022.101465_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102660","article-title":"Environmental risk factors associated with ANCA associated vasculitis: a systematic mapping review","volume":"19","author":"Scott","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0040","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood.V78.10.2542.2542","article-title":"Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils","volume":"78","author":"Yamaguchi","year":"1991","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0041","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0042","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3109\/14397595.2013.857582","article-title":"A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan","volume":"24","author":"Sada","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0043","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 immune response in Churg-Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0044","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/ar392","article-title":"Staphylococcus aureus and Wegener's granulomatosis","volume":"4","author":"Popa","year":"2002","journal-title":"Arthritis Res"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0046","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1681\/ASN.2004070609","article-title":"Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils","volume":"16","author":"Schreiber","year":"2005","journal-title":"J Am Soc Nephrol JASN"},{"issue":"8","key":"10.1016\/j.disamonth.2022.101465_bib0047","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/01.ASN.0000135058.46193.72","article-title":"Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis","volume":"15","author":"Yang","year":"2004","journal-title":"J Am Soc Nephrol JASN"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0048","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0049","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1993.98","article-title":"In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis","volume":"43","author":"Noronha","year":"1993","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0050","first-page":"3602","article-title":"Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10","volume":"160","author":"L\u00fadv\u00edksson","year":"1998","journal-title":"J Immunol Baltim Md"},{"issue":"8","key":"10.1016\/j.disamonth.2022.101465_bib0051","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.20385","article-title":"An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis","volume":"50","author":"Zhou","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0052","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/18756336MTA2lNDYc2","article-title":"Henoch-Sch\u00f6nlein purpura in children: an updated review","volume":"16","author":"Leung","year":"2020","journal-title":"Curr Pediatr Rev"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0053","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bjd.12946","article-title":"Incidence of IgA vasculitis in the adult Slovenian population","volume":"171","author":"Ho\u010devar","year":"2014","journal-title":"Br J Dermatol"},{"issue":"36","key":"10.1016\/j.disamonth.2022.101465_bib0054","doi-asserted-by":"crossref","first-page":"e12217","DOI":"10.1097\/MD.0000000000012217","article-title":"Analysis of seasonal tendencies in pediatric Henoch-Sch\u00f6nlein purpura and comparison with outbreak of infectious diseases","volume":"97","author":"Hwang","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40620-020-00846-6","article-title":"Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome","volume":"34","author":"Binet","year":"2021","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0056","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3476(05)82533-8","article-title":"Impairment of lung diffusion capacity in Sch\u00f6nlein-Henoch purpura","volume":"121","author":"Chaussain","year":"1992","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0057","first-page":"1151","article-title":"Pulmonary\u2026Henoch-Sch\u00f6nlein Purpura","volume":"79","author":"Nadrous","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.disamonth.2022.101465_bib0058","article-title":"Cryoglobulinemia due to hepatitis C with pulmonary renal syndrome","volume":"2013","author":"Abdulkarim","year":"2013","journal-title":"Case Rep Nephrol"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0059","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3899\/jrheum.080874","article-title":"Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry)","volume":"36","author":"Ramos-Casals","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/502156","article-title":"Hepatitis C virus infection and mixed cryoglobulinemia","volume":"2012","author":"Lauletta","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"17","key":"10.1016\/j.disamonth.2022.101465_bib0061","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM197710272971720","article-title":"Hepatitis B and essential mixed cryoglobulinemia","volume":"297","author":"Dienstag","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2022.101465_bib0062","first-page":"S28","article-title":"Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody","volume":"34","author":"Visentini","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0063","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/0003-4819-130-3-199902020-00027","article-title":"Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1","volume":"130","author":"Dimitrakopoulos","year":"1999","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101465_bib0064","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s10067-015-2994-y","article-title":"Rheumatologic emergencies","volume":"34","author":"Guti\u00e9rrez-Gonz\u00e1lez","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2016.00035","article-title":"Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE","volume":"7","author":"Mahajan","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0066","first-page":"30","article-title":"Dysregulation of cell death and its epigenetic mechanisms in systemic lupus erythematosus","volume":"22","author":"Wu","year":"2016","journal-title":"Mol J Synth Chem Nat Prod Chem"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0067","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/ard.2009.111021","article-title":"Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function","volume":"69","author":"Gerl","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.disamonth.2022.101465_bib0068","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T cell signaling and subsets in systemic lupus erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0069","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/0961203320903798","article-title":"Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies","volume":"29","author":"Al-Adhoubi","year":"2020","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0070","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.3390\/ijms22073766","article-title":"Advances in lupus nephritis pathogenesis: from bench to bedside","volume":"22","author":"Obri\u0219c\u0103","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0071","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/s10165-006-0540-0","article-title":"Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature","volume":"17","author":"Naniwa","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0072","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12882-021-02639-w","article-title":"Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review","volume":"23","author":"Kong","year":"2022","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0073","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0074","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0738-081X(94)90329-8","article-title":"Renal involvement in systemic sclerosis","volume":"12","author":"Steen","year":"1994","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/endo-119-2-661","article-title":"Inhibition by hydrocortisone of prostacyclin synthesis by rat aorta and its reversal with RU486","volume":"119","author":"Jeremy","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.disamonth.2022.101465_bib0076","first-page":"1616","article-title":"Goodpasture-like syndrome induced by d-penicillamine in a patient with systemic sclerosis: report and review of the literature","volume":"5","author":"Derk","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0077","article-title":"Diffuse alveolar hemorrhage, a rare presentation of polymyositis","volume":"31","author":"Samuel","year":"2020","journal-title":"Respir Med Case Rep"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0078","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1742-1241.2004.00248.x","article-title":"Renal involvement in patients with polymyositis and dermatomyositis","volume":"59","author":"Yen","year":"2005","journal-title":"Int J Clin Pract"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0079","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/08860220802353918","article-title":"Paraneoplastic polymyositis associated with crescentic glomerulonephritis","volume":"30","author":"Chiu","year":"2008","journal-title":"Ren Fail"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0080","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1097\/RHU.0000000000001187","article-title":"Perinuclear antineutrophil cytoplasmic antibodies vasculitis presenting as pulmonary-renal syndrome in a patient with a history of seropositive rheumatoid arthritis","volume":"27","author":"Kotoulas","year":"2021","journal-title":"JCR J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0081","doi-asserted-by":"crossref","first-page":"278A","DOI":"10.1016\/j.chest.2019.02.268","article-title":"Diffuse alveolar hemorrhage: a rare case of pulmonary renal syndrome in the background of seropositive rheumatoid arthritis","volume":"155","author":"Fatima","year":"2019","journal-title":"CHEST"},{"key":"10.1016\/j.disamonth.2022.101465_bib0082","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220509","article-title":"Rheumatoid arthritis causing diffuse alveolar haemorrhage: a novel therapeutic approach","volume":"2017","author":"Osman","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0083","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine"},{"issue":"3-4","key":"10.1016\/j.disamonth.2022.101465_bib0084","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS registry","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0086","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/1096-8652(200009)65:1<50::AID-AJH9>3.0.CO;2-5","article-title":"Thrombotic thrombocytopenic purpura in pulmonary-renal syndromes","volume":"65","author":"Panoskaltsis","year":"2000","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0087","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"issue":"6208","key":"10.1016\/j.disamonth.2022.101465_bib0088","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.280.6208.156-a","article-title":"Hydrallazine-induced cutaneous vasculitis","volume":"280","author":"Bernstein","year":"1980","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0089","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/s10165-009-0168-y","article-title":"Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis","volume":"19","author":"Yokogawa","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1684\/ejd.2016.2881","article-title":"The distinctive histopathology of hydralazine-associated ANCA positive vasculitis: in vivo demonstration of NETosis","volume":"27","author":"Magro","year":"2017","journal-title":"Eur J Dermatol EJD"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0091","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.10833","article-title":"Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling","volume":"48","author":"Deng","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5186","key":"10.1016\/j.disamonth.2022.101465_bib0092","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","article-title":"Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","journal-title":"Science"},{"issue":"246","key":"10.1016\/j.disamonth.2022.101465_bib0093","first-page":"845","article-title":"Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype","volume":"65","author":"Russell","year":"1987","journal-title":"Q J Med"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0094","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1378\/chest.102.5.1595","article-title":"Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure","volume":"102","author":"Stankus","year":"1992","journal-title":"CHEST"},{"key":"10.1016\/j.disamonth.2022.101465_bib0095","unstructured":"Ohtsuka M., Yamashita Y., Doi M., Hasegawa S. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody.3."},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0096","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.47.467","article-title":"Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature","volume":"47","author":"Morita","year":"2000","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0097","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2796.2001.00915.x","article-title":"Acute and chronic neutropenias. What is new?","volume":"250","author":"Palmblad","year":"2001","journal-title":"J Intern Med"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0098","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1440-1827.1997.tb04443.x","article-title":"MaPuras Gi A. Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature","volume":"47","author":"Ma Garc\u00eda-Rost\u00e1n y P\u00e9rez","year":"1997","journal-title":"Pathol Int"},{"issue":"12","key":"10.1016\/j.disamonth.2022.101465_bib0099","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2215\/CJN.03440411","article-title":"Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease","volume":"6","author":"McGrath","year":"2011","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.21037\/atm-20-4212","article-title":"Isotretinoin induced small vessel vasculitis: a life-threatening pulmonary-renal syndrome-a case report","volume":"9","author":"Annangi","year":"2021","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0102","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"Su","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0103","doi-asserted-by":"crossref","first-page":"F682","DOI":"10.1152\/ajprenal.00104.2018","article-title":"Interleukin 1 receptor (IL-1R1) activation exacerbates toxin-induced acute kidney injury","volume":"315","author":"Privratsky","year":"2018","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0104","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/08860220701274991","article-title":"The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure","volume":"29","author":"Kadiroglu","year":"2007","journal-title":"Ren Fail"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0105","doi-asserted-by":"crossref","first-page":"F1231","DOI":"10.1152\/ajprenal.00557.2012","article-title":"Tumor necrosis factor-\u03b1: regulation of renal function and blood pressure","volume":"304","author":"Ramseyer","year":"2013","journal-title":"Am J Physiol - Ren Physiol"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0106","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.disamonth.2022.101465_bib0107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front Immunol"},{"issue":"10229","key":"10.1016\/j.disamonth.2022.101465_bib0108","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0109","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12959-020-00250-x","article-title":"Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor","volume":"18","author":"Eslamifar","year":"2020","journal-title":"Thromb J"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0111","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2001-18866","article-title":"The tissue factor pathway in disseminated intravascular coagulation","volume":"27","author":"\u00d8sterud","year":"2001","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0112","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1681\/ASN.2020040419","article-title":"Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology","volume":"31","author":"Batlle","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0113","first-page":"4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol Baltim Md"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0114","doi-asserted-by":"crossref","first-page":"42714","DOI":"10.1038\/srep42714","article-title":"Complement component 5 promotes lethal thrombosis","volume":"7","author":"Mizuno","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0115","article-title":"Coagulopathy in acute kidney injury","volume":"5","author":"Samaniego-Picota","year":"2020","journal-title":"J Clin Exp Nephrol"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0116","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.disamonth.2022.101465_bib0117","article-title":"BSG\/CD147 and ACE2 receptors facilitate SARS-CoV-2 infection of human iPS cell-derived kidney podocytes","author":"Kalejaiye","year":"2021","journal-title":"BioRxiv Prepr Serv Biol"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0118","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.kint.2020.07.019","article-title":"SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule","volume":"98","author":"Werion","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.disamonth.2022.101465_bib0119","article-title":"SARS-CoV-2 causes acute kidney injury by directly infecting renal tubules","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0120","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237616","article-title":"Rhabdomyolysis and acute kidney injury in severe COVID-19 infection","volume":"13","author":"Taxbro","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.disamonth.2022.101465_bib0121","article-title":"Acute kidney injury secondary to rhabdomyolysis and COVID-19: a case report and literature review","volume":"2021","author":"Chetram","year":"2021","journal-title":"Case Rep Nephrol"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0122","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.21037\/apm-20-1198","article-title":"Left ventricular dysfunction and reversible pulmonary hypertension secondary to severe pneumonia in a background of sepsis: a case report and review of the literature","volume":"9","author":"Gitonga","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0123","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0124","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0126","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.HYP.0000120964.22281.3e","article-title":"How does angiotensin II cause renal injury?","volume":"43","author":"Long","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0127","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000499940","article-title":"Is the renin-angiotensin-aldosterone system good for the kidney in acute settings?","volume":"143","author":"Dudoignon","year":"2019","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0128","doi-asserted-by":"crossref","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","article-title":"Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)","volume":"292","author":"Grobe","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ndt\/gfi230","article-title":"Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays","volume":"21","author":"Sinico","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.disamonth.2022.101465_bib0131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.018","article-title":"Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg\u2013Strauss syndrome)","volume":"48-49","author":"Mouthon","year":"2014","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0132","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00296-020-04704-3","article-title":"Clinical and pathological characteristics of ANA\/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"41","author":"Zhao","year":"2021","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0133","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-1797.2004.00244.x","article-title":"Goodpasture's disease: antiglomerular basement membrane disease","volume":"9","author":"Erlich","year":"2004","journal-title":"Nephrology"},{"key":"10.1016\/j.disamonth.2022.101465_bib0134","article-title":"A case of pulmonary-renal syndrome leading to the diagnosis of legionnaires\u2019 disease","volume":"2016","author":"Sabani","year":"2016","journal-title":"Case Rep Nephrol"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3949\/ccjm.75.4.258","article-title":"Diffuse alveolar hemorrhage: diagnosing it and finding the cause","volume":"75","author":"Ioachimescu","year":"2008","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0136","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.151.1.7812547","article-title":"Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts","volume":"151","author":"De Lassence","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0137","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05750515","article-title":"The native kidney biopsy: update and evidence for best practice","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0138","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0272-6386(95)90592-8","article-title":"Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys","volume":"26","author":"Mendelssohn","year":"1995","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"11","key":"10.1016\/j.disamonth.2022.101465_bib0139","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/thorax.58.11.920","article-title":"Guidelines for radiologically guided lung biopsy","volume":"58","author":"Manhire","year":"2003","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","volume":"64","author":"Johnson","year":"1985","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0141","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","article-title":"Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis","volume":"57","author":"Walsh","year":"2011","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0142","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","article-title":"Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear","volume":"84","author":"Walsh","year":"2013","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0143","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0144","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey","year":"1991","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0146","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0147","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0148","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ekir.2018.12.002","article-title":"Rituximab for anti-glomerular basement membrane disease","volume":"4","author":"Jain","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.disamonth.2022.101465_bib0149","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.04.003","article-title":"Rituximab in anti-GBM disease: a retrospective study of 8 patients","volume":"60","author":"Touzot","year":"2015","journal-title":"J Autoimmun"},{"issue":"20","key":"10.1016\/j.disamonth.2022.101465_bib0150","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2022.101465_bib0151","unstructured":"G.S. Kline. Mepolizumab long-term access programme for subjects who participated in study MEA115921 (Placebo-controlled study of mepolizumab in the treatment of eosinophilic granulomatosis with polyangiitis in subjects receiving standard-of-care therapy). clinicaltrials.gov; 2022. Accessed April 27, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03298061."},{"key":"10.1016\/j.disamonth.2022.101465_bib0152","unstructured":"Jones R.A randomised, double blind, controlled mechanistic study of rituximab and belimumab combination therapy in PR3 ANCA-associated vasculitis. clinicaltrials.gov; 2022. Accessed April 27, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03967925."},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0153","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/art.40802","article-title":"Efficacy and safety of belimumab and azathioprine for maintenance of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled study","volume":"71","author":"Jayne","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.disamonth.2022.101465_bib0154","unstructured":"University of South Florida. Abatacept (CTLA4-Ig) for the treatment of relapsing, non-severe, granulomatosis with polyangiitis (Wegener's) (ABROGATE). clinicaltrials.gov; 2021. Accessed April 27, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02108860."},{"key":"10.1016\/j.disamonth.2022.101465_bib0155","unstructured":"Guy's and St Thomas\u2019 NHS Foundation Trust. Hydroxychloroquine in ANCA vasculitis evaluation - a multicentre, randomised, double-blind, placebo-controlled trial. clinicaltrials.gov; 2022. Accessed April 27, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04316494"},{"key":"10.1016\/j.disamonth.2022.101465_bib0156","unstructured":"JPRN-UMIN000024574. Clinical trial of tocilizumab versus cyclophosphamide for microscopic polyangiitis and granulomatosis with polyangiitis. HttpstrialsearchwhointTrial2aspxTrialIDJPRN-UMIN000024574. Published online March 31, 2019. doi:10.1002\/central\/CN-01886108."},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0157","doi-asserted-by":"crossref","first-page":"e14179","DOI":"10.1111\/ctr.14179","article-title":"Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease","volume":"35","author":"Singh","year":"2021","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0158","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ekir.2021.04.011","article-title":"Recurrence and outcome of anti-glomerular basement membrane glomerulonephritis after kidney transplantation","volume":"6","author":"Coche","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0159","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","article-title":"Characteristics and Outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal Association-European Dialysis and Transplant Association Registry","volume":"66","author":"Hruskova","year":"2015","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0160","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/annrheumdis-2018-213452","article-title":"Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System","volume":"77","author":"Wallace","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0161","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP)","volume":"98","author":"Dudley","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.disamonth.2022.101465_bib0162","unstructured":"Kidney Disease Improving Global Outcomes. KDIGO clinical practice guideline on glomerular diseases. Accessed May 16, 2022. https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO-GN-GL-Public-Review-Draft_1-June-2020.pdf."},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0163","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.disamonth.2022.101465_bib0164","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the apheresis applications committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apheresis"},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0166","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0167","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2016-210882","article-title":"Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial","volume":"76","author":"Ordi-Ros","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0168","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/0961203314564235","article-title":"Rituximab: an emerging treatment for recurrent diffuse alveolar hemorrhage in systemic lupus erythematosus","volume":"24","author":"Tse","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.disamonth.2022.101465_bib0169","article-title":"Therapeutic plasma exchange as management of complicated systemic lupus erythematosus and other autoimmune diseases","volume":"2019","author":"Aguirre-Valencia","year":"2019","journal-title":"Autoimmune Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2022.101465_bib0170","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/acr.22589","article-title":"Treatment algorithms in systemic lupus erythematosus","volume":"67","author":"Muangchan","year":"2015","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.disamonth.2022.101465_bib0171","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.2010.09800.x","article-title":"A first case report of a patient with paraneoplastic dermatomyositis developing diffuse alveolar haemorrhage","volume":"163","author":"Do-Pham","year":"2010","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0172","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1378\/chest.113.6.1609","article-title":"Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease","volume":"113","author":"Schwarz","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.disamonth.2022.101465_bib0173","article-title":"A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis","volume":"32","author":"Nakashima","year":"2021","journal-title":"Respir Med Case Rep"},{"issue":"7","key":"10.1016\/j.disamonth.2022.101465_bib0174","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.disamonth.2022.101465_bib0175","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/art.22018","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients","volume":"54","author":"Bucciarelli","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.disamonth.2022.101465_bib0176","article-title":"36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature","volume":"2014","author":"Strakhan","year":"2014","journal-title":"Case Rep Hematol."},{"issue":"11","key":"10.1016\/j.disamonth.2022.101465_bib0177","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.disamonth.2022.101465_bib0178","series-title":"StatPearls","article-title":"Thrombotic thrombocytopenic purpura","author":"Stanley","year":"2022"},{"issue":"5","key":"10.1016\/j.disamonth.2022.101465_bib0179","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0037-1603100","article-title":"Clinical scoring systems in thrombotic microangiopathies","volume":"43","author":"Bendapudi","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"10.1016\/j.disamonth.2022.101465_bib0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.disamonth.2022.101465_bib0181","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost JTH"},{"issue":"4","key":"10.1016\/j.disamonth.2022.101465_bib0182","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/jcm11041103","article-title":"Severe Thrombotic Thrombocytopenic Purpura (TTP) with organ failure in critically ill patients","volume":"11","author":"Fodil","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.disamonth.2022.101465_bib0183","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2011.051433","article-title":"Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura","volume":"97","author":"Froehlich-Zahnd","year":"2012","journal-title":"Haematologica"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502922001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502922001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T01:03:24Z","timestamp":1757898204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502922001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":183,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0011502922001493"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2022.101465","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2022.101465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101465"}}